Literature DB >> 1726964

Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.

T J Oglesby1, D White, I Tedja, K Liszewski, L Wright, J Van den Bogarde, J P Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1726964

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  14 in total

1.  Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.

Authors:  Evanthia Galanis; Pamela J Atherton; Matthew J Maurer; Keith L Knutson; Sean C Dowdy; William A Cliby; Paul Haluska; Harry J Long; Ann Oberg; Ileana Aderca; Matthew S Block; Jamie Bakkum-Gamez; Mark J Federspiel; Stephen J Russell; Kimberly R Kalli; Gary Keeney; Kah Whye Peng; Lynn C Hartmann
Journal:  Cancer Res       Date:  2014-11-14       Impact factor: 12.701

2.  Adenovirus type 11 uses CD46 as a cellular receptor.

Authors:  Anna Segerman; John P Atkinson; Marko Marttila; Veronica Dennerquist; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p.

Authors:  Dan J Gustafsson; Anna Segerman; Kristina Lindman; Ya-Fang Mei; Göran Wadell
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  Overcoming the barriers to xenotransplantation: prospects for the future.

Authors:  Burcin Ekser; David K C Cooper
Journal:  Expert Rev Clin Immunol       Date:  2010-03       Impact factor: 4.473

5.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

6.  Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.

Authors:  M Manchester; M K Liszewski; J P Atkinson; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Authors:  Evanthia Galanis; Lynn C Hartmann; William A Cliby; Harry J Long; Prema P Peethambaram; Brigitte A Barrette; Judith S Kaur; Paul J Haluska; Ileana Aderca; Paula J Zollman; Jeff A Sloan; Gary Keeney; Pamela J Atherton; Karl C Podratz; Sean C Dowdy; C Robert Stanhope; Timothy O Wilson; Mark J Federspiel; Kah-Whye Peng; Stephen J Russell
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

8.  Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.

Authors:  T J Oglesby; C J Allen; M K Liszewski; D J White; J P Atkinson
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

9.  Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.

Authors:  C Allen; M Opyrchal; I Aderca; M A Schroeder; J N Sarkaria; E Domingo; M J Federspiel; E Galanis
Journal:  Gene Ther       Date:  2012-08-23       Impact factor: 5.250

10.  A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis.

Authors:  Kenneth J Katschke; Karim Y Helmy; Micah Steffek; Hongkang Xi; Jianping Yin; Wyne P Lee; Peter Gribling; Kai H Barck; Richard A D Carano; Robin E Taylor; Linda Rangell; Lauri Diehl; Philip E Hass; Christian Wiesmann; Menno van Lookeren Campagne
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.